Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?

Fig. 2

Lifetime incident cervical cancer cases per each cohort of 281,000 females under different prevention strategies targeting females (screening: 65 % screened every 3 years from 25 to 64; vaccination: 100 % vaccination coverage) used as input to the assessment model. Legend: CC cervical cancer

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us